Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
5.9% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
26
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
9
users have commented on this narrative
25
users have followed this narrative
11 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
19
users have liked this narrative
7
users have commented on this narrative
22
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
44.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Sangamo Therapeutics
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
FDA Approval In 2026 Will Extend Fabry Gene Therapy Prospects
Key Takeaways Positive clinical data in Fabry disease and strong market enthusiasm position Sangamo for rapid adoption, margin improvement, and significant revenue growth upon approval. Progress in non-opioid neurology therapeutics, industry partnerships, and global regulatory trends expand the pipeline, derisk funding, and boost long-term revenue prospects.
View narrative
US$4.10
FV
85.7% undervalued
intrinsic discount
27.13%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
14
users have followed this narrative
9 days ago
author updated this narrative
SIG
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
Europe Infrastructure Investment And Green Construction Will Transform Markets
Key Takeaways Strategic restructuring, innovation, and digital enhancements position SIG for growth, margin expansion, and increased market share as demand for sustainable construction rises. Sector consolidation and growing regulatory complexity favor SIG over smaller competitors, enabling stronger revenue growth and long-term profitability.
View narrative
UK£0.17
FV
33.3% undervalued
intrinsic discount
3.06%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
2
users have followed this narrative
9 days ago
author updated this narrative
Amarin
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
International Growth With Recordati Will Face Risks And Rewards
Key Takeaways Heavy reliance on international expansion and partner execution may not sufficiently offset domestic declines due to regulatory, pricing, and market access risks. Single-product concentration and shift to royalty revenue heighten earnings unpredictability and exposure to generics and competitive pressures.
View narrative
US$11.00
FV
45.3% overvalued
intrinsic discount
-13.28%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
10
users have followed this narrative
9 days ago
author updated this narrative
HomeToGo
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Digital Booking And AI Will Redefine Global Accommodations
Key Takeaways Growing digital payments and AI-driven efficiencies are enhancing margins, operational leverage, and user experience, fueling further revenue and EBITDA improvements. Expansion of direct property inventory and the B2B segment is solidifying exclusive supply, boosting high-margin recurring revenue, and strengthening the brand's global footprint.
View narrative
€4.10
FV
60.2% undervalued
intrinsic discount
31.11%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
9 days ago
author updated this narrative
ITM Power
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
EU Renewable Hydrogen Demand Will Spur Electrolyzer Capacity Expansion
Key Takeaways EU hydrogen strategy could boost ITM's revenues due to increased demand for their technology as electrolyzer capacity expands. Operational improvements and strategic initiatives enhance margins, revenue growth, and competitiveness while preserving cash flow.
View narrative
UK£0.87
FV
19.1% undervalued
intrinsic discount
54.29%
Revenue growth p.a.
Set Fair Value
2
users have liked this narrative
0
users have commented on this narrative
37
users have followed this narrative
9 days ago
author updated this narrative
Aquestive Therapeutics
AN
AnalystConsensusTarget
Consensus Narrative from 9 Analysts
Upcoming FDA Approval Will Enable Needle-Free Epinephrine Adoption
Key Takeaways The FDA review and potential success of Anaphylm could drive strong revenue growth and shift market preference toward needle-free drug delivery. Strategic investments in awareness, payer access, and product pipeline position the company for rapid adoption, diversified revenue, and improved margins.
View narrative
US$8.42
FV
52.7% undervalued
intrinsic discount
42.06%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
9 days ago
author updated this narrative
Capricorn Energy
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Egypt Concessions And North Sea Assets Will Create Mixed Outcomes
Key Takeaways Extended concession agreements in Egypt could unlock reserves, improve production, and drive future revenue growth. Acquiring high-value assets in the U.K. North Sea without liabilities offers revenue diversification and incremental earnings opportunities.
View narrative
UK£3.33
FV
35.7% undervalued
intrinsic discount
0.94%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
9 days ago
author updated this narrative
CS Disco
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Cloud Native AI Legal Tech Will Transform Global Markets
Key Takeaways Expanding AI-driven legal tech offerings and international growth are boosting CS Disco's market presence, recurring revenue, and pricing power. Streamlined operations and enterprise client focus are improving margins, sales efficiency, and supporting a path to long-term profitability.
View narrative
US$6.08
FV
14.6% undervalued
intrinsic discount
8.07%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
9 days ago
author updated this narrative
eHealth
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Growing US Senior Demand Will Fuel Digital Medicare Expansion
Key Takeaways Expansion of the senior market and digital adoption, combined with tech investments, boost growth potential, customer efficiency, and margin stability. Industry consolidation and favorable commission trends position eHealth to capture greater market share and drive future revenue and earnings gains.
View narrative
US$9.50
FV
59.6% undervalued
intrinsic discount
3.95%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
9 days ago
author updated this narrative
Value any company in seconds
Popular companies